Literature DB >> 20650402

Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment.

Ralf Baron1, Andreas Binder, Gunnar Wasner.   

Abstract

Neuropathic pain develops as a result of lesions or disease affecting the somatosensory nervous system either in the periphery or centrally. Examples of neuropathic pain include painful polyneuropathy, postherpetic neuralgia, trigeminal neuralgia, and post-stroke pain. Clinically, neuropathic pain is characterised by spontaneous ongoing or shooting pain and evoked amplified pain responses after noxious or non-noxious stimuli. Methods such as questionnaires for screening and assessment focus on the presence and quality of neuropathic pain. Basic research is enabling the identification of different pathophysiological mechanisms, and clinical assessment of symptoms and signs can help to determine which mechanisms are involved in specific neuropathic pain disorders. Management of neuropathic pain requires an interdisciplinary approach, centred around pharmacological treatment. A better understanding of neuropathic pain and, in particular, of the translation of pathophysiological mechanisms into sensory signs will lead to a more effective and specific mechanism-based treatment approach. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20650402     DOI: 10.1016/S1474-4422(10)70143-5

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  374 in total

1.  Differential expression and functionality of TRPA1 protein genetic variants in conditions of thermal stimulation.

Authors:  Denisa May; Jonas Baastrup; Maria Raphaela Nientit; Andreas Binder; Michael Schünke; Ralf Baron; Ingolf Cascorbi
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

2.  [Physicians do not treat averages--but therapy responders!].

Authors:  C Maier; R Baron
Journal:  Schmerz       Date:  2012-02       Impact factor: 1.107

3.  Repurposing a leukocyte elastase inhibitor for neuropathic pain.

Authors:  Andy D Weyer; Cheryl L Stucky
Journal:  Nat Med       Date:  2015-05       Impact factor: 53.440

Review 4.  Fabry disease: a rare cause of neuropathic pain.

Authors:  Marieke Biegstraaten; Gabor E Linthorst; Ivo N van Schaik; Carla E M Hollak
Journal:  Curr Pain Headache Rep       Date:  2013-10

5.  Cutaneous Aβ-Non-nociceptive, but Not C-Nociceptive, Dorsal Root Ganglion Neurons Exhibit Spontaneous Activity in the Streptozotocin Rat Model of Painful Diabetic Neuropathy in vivo.

Authors:  Laiche Djouhri; Asad Zeidan; Seham A Abd El-Aleem; Trevor Smith
Journal:  Front Neurosci       Date:  2020-05-25       Impact factor: 4.677

Review 6.  Zonisamide for neuropathic pain in adults.

Authors:  R Andrew Moore; Philip J Wiffen; Sheena Derry; Michael P T Lunn
Journal:  Cochrane Database Syst Rev       Date:  2015-01-22

Review 7.  Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain.

Authors:  N Percie du Sert; A S C Rice
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

Review 8.  The Pharmacological Therapy of Chronic Neuropathic Pain.

Authors:  Andreas Binder; Ralf Baron
Journal:  Dtsch Arztebl Int       Date:  2016-09-16       Impact factor: 5.594

9.  Rapamycin ameliorates neuropathic pain by activating autophagy and inhibiting interleukin-1β in the rat spinal cord.

Authors:  Tao Feng; Qin Yin; Ze-Lin Weng; Jian-Cheng Zhang; Kun-Feng Wang; Shi-Ying Yuan; Wei Cheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-12-06

10.  Different Phenotyping Approaches Lead to Dissimilar Biologic Profiles in Men With Chronic Fatigue After Radiation Therapy.

Authors:  Li Rebekah Feng; Kristin Dickinson; Neila Kline; Leorey N Saligan
Journal:  J Pain Symptom Manage       Date:  2016-08-09       Impact factor: 3.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.